Basic Manufacturing Process of AJAX™

Patented Technology

■ This mechanism is designed to encompass the interaction between the hydrophilic group and hydrophobic one by means of patented method with a view to performing both prompt implantations and cell proliferations.
■ First endocoating for protection and activation of the purified vitamin A via patented process.

■ Enlargement of the reaction surface of primary HA gel.
■  Second ectocoating which utilizes cross-linking reagent for consistent extrusion force and
superb viscoelasticity.
■ Terminal cross-linking & purification.
■ Mode of action
The results of this action suggest that the combination of cross-linked purified vitamin A and a
highly biocompatible liquid polymer medium such as reticulated HA, pullulan as a polysaccha
ride, induced significant but safe tissue augmentation and collagen formation. fulfils the
expectations of a safe and efficient extended dermal filler as a sustained release material that is conjugated and activated by revolutionary method even if the implant life of cross-linked hyaluronic acid is terminated.

We Promise,

Activator Protein-1(AP-1)
Transcription factor that inhibits collagen production and up-regulates collagen breakdown

Matrix MetalloProteinases(MMPs)
Enzyme of collagen breakdown

Transforming Growth Factor-β(TGF-β)
A cytokine that promotes collagen pr oduction

■ PECULIARITY OF VITAMIN A
■ COLLAGEN AND ELASTIN FIBBER PRODUCTION & CELL PROLIFERATION

We Support,

■ LUBRICANT & PAIN CONTROL OF INJECTION
■ ANTIOXIDANT PROPERTY

We Guarantee,

■ DISSERTATION ABSTRACT ON VITAMON A DERMAL FILLER COMBINED WITH CROSS LINKED HA
■ FUNDAMENTAL PRODUCT DATA FOR IMMEDIATE WRINKLE CORRECTION
■ OPTIMIZED VISCOELASTICITY